Back to search
FDAFDA · Food and drugs·Recall number D-0615-2022

No Drip Nasal Mist, Oxymetazoline HCl 0.05% Nasal decongestant, 1 FL Oz (30 mL) per bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 59779-388-10

Published March 2, 2022 · Recall initiated: October 26, 2021

Summary

FDA records drug Class II recall D-0615-2022, published March 2, 2022 and initiated October 26, 2021. Recalling firm: Perrigo Company PLC; Status: Terminated; Reported quantity: 64,512 bottles; Lot: Batch: 1FK1164, Exp 01/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What to do

Voluntary: Firm initiated · Letter

Get an email if NASAL MIST has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NASAL MIST
Manufacturer
Perrigo Company PLC
Distributor
Nationwide in the USA
Lot
Batch: 1FK1164, Exp 01/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was No Drip Nasal Mist, Oxymetazoline HCl 0.05% Nasal decongestant, 1 FL Oz (30 mL) per bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 59779-388-10 recalled?

Yes. FDA published recall D-0615-2022 on March 2, 2022. Reported hazard: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NASAL MIST.